Classical Hodgkin's lymphoma: past, present and future perspectives.
Haematology Specialist Registrar in the Department of Haematology, Cancer and Haematology Centre, Oxford University Hospitals NHS Trust, Oxford.
Toby A
TA
Eyre
Andrew J
AJ
King
Graham P
GP
Collins
D000367:Age Factors; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001761:Bleomycin / Q000627:therapeutic use; D000079963:Brentuximab Vedotin; D059248:Chemoradiotherapy; D003606:Dacarbazine / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D006689:Hodgkin Disease / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*; D006801:Humans; D018796:Immunoconjugates / Q000627:therapeutic use; D009367:Neoplasm Staging; D049268:Positron-Emission Tomography; D011379:Prognosis; D012737:Sex Factors; D033581:Stem Cell Transplantation; D014747:Vinblastine / Q000627:therapeutic use
D018796:Immunoconjugates; D001761:Bleomycin; D014747:Vinblastine; D003606:Dacarbazine; D000079963:Brentuximab Vedotin; D004317:Doxorubicin